Skip to main content
. 2015 Oct 23;4(1):18–22. doi: 10.3892/mco.2015.662

Figure 2.

Figure 2.

Survival probabiliy in different zinc finger E-box-binding homeobox factor 1 (ZEB1) expression groups. (A) The group with positive ZEB1 expression in ovarian carcinoma cells had a poorer 5-year progression-free survival compared with the negative group (P=0.021, Kaplan-Meier method). (B) The ZEB1-negative group exhibited a trend for better 5-year-overall survival compared with the positive group, but the difference did not reach statistical significance (P=0.118, Kaplan-Meier method).